Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
biotech
3
×
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
3
×
crispr
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
3
×
texas blog main
texas top stories
wisconsin blog main
3
×
wisconsin top stories
allergan
alzheimer's disease
biogen
boston top stories
cancer immunotherapy
deals
eli lilly
europe blog main
europe top stories
What
bio
roundup
companies
acquisitions
announced
approval
biogen’s
biopharmaceutical
black
ceo
collabs
continue
convo
covid
daniel
deal
debut
diamond
diamond’s
drug
earlier
failures
gilead
gilead’s
help
indication
introduce
ipo
leading
life
littered
mammoth
march
medicines
month
moves
nash
new
news
ohana’s
Language
unset
Current search:
crispr
×
biotech
×
startups
×
" clinical trials "
×
" wisconsin blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More